Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

106.09 +0.04 (+0.04%)

Official Closing Price Updated: 6:30 PM EST, Jan 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

52 53 Next >

EU Rushes To Scrap Tariffs On US Goods To Unlock Lower American Auto Duties: These Exporters Stand To Gain Big ↗

August 27, 2025

EU set to scrap tariffs on U.S. goods in a key auto trade deal. See which American industrial and energy stocks are poised for a boost.

Via Benzinga

Topics World Trade

3 Unstoppable Dividend Stocks to Buy Right Now ↗

August 23, 2025

Investors will get great dividends and more with these stocks.

Via The Motley Fool

Topics World Trade

2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer ↗

August 21, 2025

These high-yield dividend stocks are built to last.

Via The Motley Fool

Topics Intellectual Property

Abbott Laboratories (NYSE:ABT): A High-Quality Dividend Stock with Strong Growth and Financial Health ↗

July 28, 2025

Via Chartmill

P/E Ratio Insights for Abbott Laboratories ↗

July 17, 2025

Via Benzinga

1 Cash-Producing Stock for Long-Term Investors and 2 We Question

August 19, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

2 Stocks to Buy on the Dip and Hold for 10 Years ↗

August 16, 2025

There should be plenty of long-term upside for these stocks for investors willing to ride out the storm.

Via The Motley Fool

Topics Economy Government

Looking Into Abbott Laboratories's Recent Short Interest ↗

August 15, 2025

Via Benzinga

3 Dividend Stocks to Double Up On Right Now ↗

August 15, 2025

These stocks offer great dividends and more.

Via The Motley Fool

Topics Economy Government World Trade

1 Healthcare Stock for Long-Term Investors and 2 We Ignore

August 15, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the...

Via StockStory

Topics Stocks

Recent Filing Shows That Rep. Josh Gottheimer Sold Over $6K Worth of Abbott Laboratories Stock ↗

August 12, 2025

Via Benzinga

3 Stocks Retirees Should Absolutely Love ↗

August 09, 2025

These stocks check off all the boxes for investors no longer receiving a paycheck.

Via The Motley Fool

Topics Economy Retirement

Medical Devices & Supplies - Diversified Stocks Q2 Highlights: Abbott Laboratories (NYSE:ABT)

August 05, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Abbott Laboratories (NYSE:ABT) and its peers.

Via StockStory

The August-September Slump: Understanding Seasonal Trends in the Stock Market

August 05, 2025

As the summer months draw to a close, a familiar pattern emerges on Wall Street: the historical August-September slump. This seasonal weakness, particularly pronounced in the S&P 500, is once again...

Via MarketMinute

Topics Economy Stocks World Trade

2 Top Stocks to Buy Now If You Want Decades of Passive Income ↗

August 01, 2025

These companies have provided strong returns to long-term shareholders, but they aren't done yet.

Via The Motley Fool

Topics Credit Cards

Abbott Laboratories (NYSE:ABT) Meets the Caviar Cruise Quality Investing Standards ↗

July 31, 2025

The Caviar Cruise strategy identifies high-quality stocks like Abbott Labs (ABT) with steady growth, strong ROIC, low debt, and reliable cash flow for long-term investors.

Via Chartmill

This New ETF Brings Out The Best In S&P 500 Without The Tech Overload ↗

July 30, 2025

Xtrackers SPXD ETF offers a balanced way to invest in S&P 500 without relying on tech giants like Nvidia. Its innovative approach prioritizes actual economic activity and has affordable fees.

Via Benzinga

Topics ETFs Stocks

The Smartest Dividend Stocks to Buy With $350 Right Now ↗

July 26, 2025

These stocks offer juicy dividends, solid growth prospects, and stability.

Via The Motley Fool

5 Dividend Stocks to Hold for the Next 20 Years ↗

July 25, 2025

Discover five unstoppable dividend stocks that could pay you for life, and why I wouldn't sell any of them!

Via The Motley Fool

What's going on in today's session: S&P500 movers ↗

July 18, 2025

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

Looking Into Abbott Laboratories's Recent Short Interest ↗

July 18, 2025

Via Benzinga

Invesco, Vistra, Dell, Coinbase Trend In Midday Trade: S&P 500 Hits Record High ↗

July 18, 2025

Via Stocktwits

Topics Stocks

These S&P500 stocks have an unusual volume in today's session ↗

July 18, 2025

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.

Via Chartmill

Top S&P500 movers in Friday's session ↗

July 18, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield ↗

July 18, 2025

Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity.

Via MarketBeat

These Analysts Revise Their Forecasts On Abbott Following Q2 Results ↗

July 18, 2025

Via Benzinga

Microsoft To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday ↗

July 18, 2025

Via Benzinga

ABT Q1 Deep Dive: Growth in Devices, Product Pipeline, and Tariff Mitigation Shape Outlook

July 18, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of...

Via StockStory

Topics Economy World Trade

Abbott Reports 12% Growth in Device Sales ↗

July 17, 2025

Via The Motley Fool

Top S&P500 movers in Thursday's session ↗

July 17, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

52 53 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.